2312.0000 99.40 (4.49%)
NSE Oct 26, 2026 15:58 PM
Volume: 1.0M
 

Motilal Oswal
MANKIND has a strategic roadmap for growth through expansion in high entry barrier innovative product launches in the chronic/consumer segment and other adjacencies, transitioning from sexual wellness to consumer wellness in the over-the counter (OTC) space.
Mankind Pharma Ltd.'s price crossed above 200Day SMA today
More from Mankind Pharma Ltd.
All Rapid Results
Recommended